Recruiting Pulmonary Embolism Studies in Cooper City
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hy...
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
About Pulmonary Embolism Clinical Trials in Cooper City
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Cooper City, FL. These studies are seeking a combined 530 participants. Research is being sponsored by Novartis Pharmaceuticals, vTv Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Cooper City — FAQ
Are there pulmonary embolism clinical trials in Cooper City?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Cooper City, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cooper City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cooper City research site will contact you about next steps.
Are clinical trials in Cooper City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cooper City studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Cooper City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov